Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NEXGEL, INC.NXGL · Entity 8400 | Director | August 17, 2023 | August 21, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NEXGEL, INC.
Report date August 17, 2023 · Filed August 21, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.05 · Expires 2033-08-17 | Direct | 15,000 |
Reported balance
After 2023-08-17 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-08-17 · Grant · Acquired 15,000 · Balance 15,000 F1: Represents stock options granted pursuant to the Issuer's 2019 Long-Term Incentive Plan, as amended, for past services as a member of the Issuer's Board of Directors. The total number of shares vested as of August 17, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents stock options granted pursuant to the Issuer's 2019 Long-Term Incentive Plan, as amended, for past services as a member of the Issuer's Board of Directors. The total number of shares vested as of August 17, 2023.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 17, 2023 Filed Aug 21, 2023 20:34 UTC | NEXGEL, INC. NXGL · Entity 8400 | GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $2.05 | $0.00 |
DisclosureSEC source: 0001493152-23-029650 · ownership.xml · derivative · entry 1 STEFANSKY DAVID · CIK 0001320581 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2033-08-17 F1 · derivative.exercise_date: Represents stock options granted pursuant to the Issuer's 2019 Long-Term Incentive Plan, as amended, for past services as a member of the Issuer's Board of Directors. The total number of shares vested as of August 17, 2023. Read SEC document |
| June 08, 2023 Filed Jun 9, 2023 12:30 UTC | NEXGEL, INC. NXGL · Entity 8400 | PurchaseCommon Stock | 1,000 | $2.22 | $2,220.00 |
DisclosureSEC source: 0001493152-23-020659 · ownership.xml · nonDerivative · entry 2 STEFANSKY DAVID · CIK 0001320581 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,091 F2 · price: The Reporting Person purchased all 1,000 shares of common stock in the open market at a price of $2.22 per share. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 12:30 UTC | NEXGEL, INC. NXGL · Entity 8400 | PurchaseCommon Stock | 2,000 | $2.50 | $5,000.00 |
DisclosureSEC source: 0001493152-23-020659 · ownership.xml · nonDerivative · entry 1 STEFANSKY DAVID · CIK 0001320581 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,091 F1 · price: The Reporting Person purchased all 2,000 shares of common stock in the open market at a price of $2.50 per share. Read SEC document |
| May 31, 2023 Filed Jun 1, 2023 12:30 UTC | NEXGEL, INC. NXGL · Entity 8400 | PurchaseCommon Stock | 2,000 | $2.42 | $4,840.00 |
DisclosureSEC source: 0001493152-23-019751 · ownership.xml · nonDerivative · entry 2 STEFANSKY DAVID · CIK 0001320581 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,091 F2 · price: The Reporting Person purchased all 2,000 shares of common stock in the open market at a price of $2.42 per share. Read SEC document |
| May 30, 2023 Filed Jun 1, 2023 12:30 UTC | NEXGEL, INC. NXGL · Entity 8400 | PurchaseCommon Stock | 5,000 | $2.53 | $12,650.00 |
DisclosureSEC source: 0001493152-23-019751 · ownership.xml · nonDerivative · entry 1 STEFANSKY DAVID · CIK 0001320581 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,091 F1 · price: Represents the weighted average of open market purchase transactions ranging from $2.40 to $2.65 per share. The Reporting Person undertakes to provide full information regarding the number of shares purchased at each separate price paid if requested by the Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer. Read SEC document |
| December 19, 2022 Filed Dec 19, 2022 21:25 UTC | NEXGEL, INC. NXGL · Entity 8400 | PurchaseCommon Stock | 5,000 | $1.59 | $7,950.00 |
DisclosureSEC source: 0001493152-22-035878 · ownership.xml · nonDerivative · entry 1 STEFANSKY DAVID · CIK 0001320581 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,091 F1 · price: The Reporting Person purchased all 5,000 shares of common stock in the open market at a price of $1.59 per share. Read SEC document |
| December 12, 2022 Filed Dec 13, 2022 21:11 UTC | NEXGEL, INC. NXGL · Entity 8400 | PurchaseCommon Stock | 7,500 | $1.44 | $10,824.75 |
DisclosureSEC source: 0001493152-22-035308 · ownership.xml · nonDerivative · entry 1 STEFANSKY DAVID · CIK 0001320581 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,091 F1 · price: The $1.4433 represents a weighted average price. The Reporting Person purchased 5,000 shares of common stock in the open market at a price of $1.44 per share and purchased 2,500 shares of common stock in the open market at a price of $1.45 per share. Read SEC document |
| August 30, 2022 Filed Aug 31, 2022 13:00 UTC | NEXGEL, INC. NXGL · Entity 8400 | PurchaseCommon Stock | 5,000 | $1.66 | $8,280.00 |
DisclosureSEC source: 0001493152-22-024446 · ownership.xml · nonDerivative · entry 1 STEFANSKY DAVID · CIK 0001320581 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,591 F1 · price: The $1.6560 represents a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.6400 to $1.6800. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote 1 to this Form 4. Read SEC document |
| August 25, 2022 Filed Aug 26, 2022 13:00 UTC | NEXGEL, INC. NXGL · Entity 8400 | PurchaseCommon Stock | 5,000 | $1.73 | $8,650.00 |
DisclosureSEC source: 0001493152-22-024116 · ownership.xml · nonDerivative · entry 1 STEFANSKY DAVID · CIK 0001320581 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,591 Read SEC document |
| August 16, 2022 Filed Aug 17, 2022 13:00 UTC | NEXGEL, INC. NXGL · Entity 8400 | PurchaseCommon Stock | 2,500 | $1.79 | $4,480.00 |
DisclosureSEC source: 0001493152-22-023279 · ownership.xml · nonDerivative · entry 2 STEFANSKY DAVID · CIK 0001320581 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,591 F2 · price: The $1.7920 represents a weighted average price. The Reporting Person purchased 500 shares of common stock at a price of $1.800 per share and 2,000 shares of common stock at a price of $1.7900 per share. Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 13:00 UTC | NEXGEL, INC. NXGL · Entity 8400 | PurchaseCommon Stock | 2,872 | $1.90 | $5,466.28 |
DisclosureSEC source: 0001493152-22-023279 · ownership.xml · nonDerivative · entry 1 STEFANSKY DAVID · CIK 0001320581 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,091 F1 · price: The $1.9033 represents a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.8800 to $1.9100. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote 1 to this Form 4. Read SEC document |
| June 24, 2022 Filed Jun 27, 2022 13:00 UTC | NEXGEL, INC. NXGL · Entity 8400 | PurchaseCommon Stock | 3,128 | $1.60 | $4,992.91 |
DisclosureSEC source: 0001493152-22-017807 · ownership.xml · nonDerivative · entry 1 STEFANSKY DAVID · CIK 0001320581 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,219 F1 · price: The $1.5962 represents a weighted average price. The Reporting Person purchased 3,000 shares of common stock at a price of $1.60 per share, 100 shares of common stock at a price of $1.59 per share and 28 shares of common stock at a price of $1.55 per share. F1 · balance_after: The $1.5962 represents a weighted average price. The Reporting Person purchased 3,000 shares of common stock at a price of $1.60 per share, 100 shares of common stock at a price of $1.59 per share and 28 shares of common stock at a price of $1.55 per share. Read SEC document |
| December 27, 2021 Filed Jan 3, 2022 21:44 UTC | NEXGEL, INC. NXGL · Entity 8400 | GrantWarrant to Purchase Common Stock · Derivative | 9,091 | $0.01 Strike: $5.50 | $90.91 |
DisclosureSEC source: 0001104659-22-000433 · tm221361-2_4seq1.xml · derivative · entry 3 STEFANSKY DAVID · CIK 0001320581 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,091 Underlying: Common Stock · 9,091 shares Expires 2026-12-26 F1 · kind: The Reporting Person acquired the shares of common stock and warrant to purchase common stock reported on this Form 4 in connection with the Issuer's underwritten public offering which closed on December 27, 2021. Read SEC document |
| December 27, 2021 Filed Jan 3, 2022 21:44 UTC | NEXGEL, INC. NXGL · Entity 8400 | PurchaseCommon Stock | 9,091 | $5.49 | $49,909.59 |
DisclosureSEC source: 0001104659-22-000433 · tm221361-2_4seq1.xml · nonDerivative · entry 1 STEFANSKY DAVID · CIK 0001320581 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,091 F1 · acquired: The Reporting Person acquired the shares of common stock and warrant to purchase common stock reported on this Form 4 in connection with the Issuer's underwritten public offering which closed on December 27, 2021. Read SEC document |
| February 17, 2020 Filed Jun 9, 2020 18:52 UTC | NEXGEL, INC. NONE · Entity 8400 | GrantOption to Purchase Common Stock · Derivative | 2,857,141 | $0.00 Strike: $0.01 | $0.00 |
DisclosureSEC source: 0001104659-20-071294 · tm2022182d2_4.xml · derivative · entry 2 STEFANSKY DAVID · CIK 0001320581 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,857,141 Underlying: Common Stock · 2,857,141 shares Expires 2030-02-17 F2 · derivative.exercise_price: On February 17, 2020 and consideration for the Reporting Person's service on the Issuer's Board of Directors (the "Board"), the Issuer granted to the Reporting Person two annual awards of stock options equal to $40,000 of the Issuer's common stock, granted under the Issuer 2019 Long-Term Incentive Plan (the "Incentive Plan"), with (i) the first grant being the right to purchase up to 2,857,141 shares of the Issuer's common stock at a per share exercise price of $0.014 with one-half of such option vesting on March 31, 2020 and the remaining one-half vesting in equal installments on June 30, 2020 and September 30, 2020, respectively, and with an acceleration of any unvested options upon the departure of the Reporting Person from the Board for any reason and F3 · derivative.exercise_price: (ii) the second grant being the right to purchase up to a number of shares of the Issuer's common stock equal to $40,000 divided by the Fair Market Value (as defined in the Incentive Plan) of the Issuer's common stock as of October 10, 2020 at a per share exercise price equal to Fair Market Value of the Issuer's common stock as of October 10, 2020 with one-fourth of such option vesting on each of December 31, 2020, March 31, 2021, June 30, 2021 and September 30, 2021, respectively, and with an acceleration of any unvested options upon the departure of the Reporting Person from the Board for any reason. This award was reported in the Issuer's Form 10-Q for the period ended March 31, 2020. F1 · kind: Represents shares of common stock held by Bezalel Partners LLC ("Bezalel"). The Reporting Person is the managing member of Bezalel and has the sole power to vote and direct the voting of, and to dispose and to direct the disposition of, the shares of common stock beneficially owned by Bezalel. F2 · shares: On February 17, 2020 and consideration for the Reporting Person's service on the Issuer's Board of Directors (the "Board"), the Issuer granted to the Reporting Person two annual awards of stock options equal to $40,000 of the Issuer's common stock, granted under the Issuer 2019 Long-Term Incentive Plan (the "Incentive Plan"), with (i) the first grant being the right to purchase up to 2,857,141 shares of the Issuer's common stock at a per share exercise price of $0.014 with one-half of such option vesting on March 31, 2020 and the remaining one-half vesting in equal installments on June 30, 2020 and September 30, 2020, respectively, and with an acceleration of any unvested options upon the departure of the Reporting Person from the Board for any reason and F3 · shares: (ii) the second grant being the right to purchase up to a number of shares of the Issuer's common stock equal to $40,000 divided by the Fair Market Value (as defined in the Incentive Plan) of the Issuer's common stock as of October 10, 2020 at a per share exercise price equal to Fair Market Value of the Issuer's common stock as of October 10, 2020 with one-fourth of such option vesting on each of December 31, 2020, March 31, 2021, June 30, 2021 and September 30, 2021, respectively, and with an acceleration of any unvested options upon the departure of the Reporting Person from the Board for any reason. This award was reported in the Issuer's Form 10-Q for the period ended March 31, 2020. F2 · price: On February 17, 2020 and consideration for the Reporting Person's service on the Issuer's Board of Directors (the "Board"), the Issuer granted to the Reporting Person two annual awards of stock options equal to $40,000 of the Issuer's common stock, granted under the Issuer 2019 Long-Term Incentive Plan (the "Incentive Plan"), with (i) the first grant being the right to purchase up to 2,857,141 shares of the Issuer's common stock at a per share exercise price of $0.014 with one-half of such option vesting on March 31, 2020 and the remaining one-half vesting in equal installments on June 30, 2020 and September 30, 2020, respectively, and with an acceleration of any unvested options upon the departure of the Reporting Person from the Board for any reason and F3 · price: (ii) the second grant being the right to purchase up to a number of shares of the Issuer's common stock equal to $40,000 divided by the Fair Market Value (as defined in the Incentive Plan) of the Issuer's common stock as of October 10, 2020 at a per share exercise price equal to Fair Market Value of the Issuer's common stock as of October 10, 2020 with one-fourth of such option vesting on each of December 31, 2020, March 31, 2021, June 30, 2021 and September 30, 2021, respectively, and with an acceleration of any unvested options upon the departure of the Reporting Person from the Board for any reason. This award was reported in the Issuer's Form 10-Q for the period ended March 31, 2020. F2 · derivative.exercise_date: On February 17, 2020 and consideration for the Reporting Person's service on the Issuer's Board of Directors (the "Board"), the Issuer granted to the Reporting Person two annual awards of stock options equal to $40,000 of the Issuer's common stock, granted under the Issuer 2019 Long-Term Incentive Plan (the "Incentive Plan"), with (i) the first grant being the right to purchase up to 2,857,141 shares of the Issuer's common stock at a per share exercise price of $0.014 with one-half of such option vesting on March 31, 2020 and the remaining one-half vesting in equal installments on June 30, 2020 and September 30, 2020, respectively, and with an acceleration of any unvested options upon the departure of the Reporting Person from the Board for any reason and F3 · derivative.exercise_date: (ii) the second grant being the right to purchase up to a number of shares of the Issuer's common stock equal to $40,000 divided by the Fair Market Value (as defined in the Incentive Plan) of the Issuer's common stock as of October 10, 2020 at a per share exercise price equal to Fair Market Value of the Issuer's common stock as of October 10, 2020 with one-fourth of such option vesting on each of December 31, 2020, March 31, 2021, June 30, 2021 and September 30, 2021, respectively, and with an acceleration of any unvested options upon the departure of the Reporting Person from the Board for any reason. This award was reported in the Issuer's Form 10-Q for the period ended March 31, 2020. F2 · derivative.underlying_shares: On February 17, 2020 and consideration for the Reporting Person's service on the Issuer's Board of Directors (the "Board"), the Issuer granted to the Reporting Person two annual awards of stock options equal to $40,000 of the Issuer's common stock, granted under the Issuer 2019 Long-Term Incentive Plan (the "Incentive Plan"), with (i) the first grant being the right to purchase up to 2,857,141 shares of the Issuer's common stock at a per share exercise price of $0.014 with one-half of such option vesting on March 31, 2020 and the remaining one-half vesting in equal installments on June 30, 2020 and September 30, 2020, respectively, and with an acceleration of any unvested options upon the departure of the Reporting Person from the Board for any reason and F3 · derivative.underlying_shares: (ii) the second grant being the right to purchase up to a number of shares of the Issuer's common stock equal to $40,000 divided by the Fair Market Value (as defined in the Incentive Plan) of the Issuer's common stock as of October 10, 2020 at a per share exercise price equal to Fair Market Value of the Issuer's common stock as of October 10, 2020 with one-fourth of such option vesting on each of December 31, 2020, March 31, 2021, June 30, 2021 and September 30, 2021, respectively, and with an acceleration of any unvested options upon the departure of the Reporting Person from the Board for any reason. This award was reported in the Issuer's Form 10-Q for the period ended March 31, 2020. F2 · balance_after: On February 17, 2020 and consideration for the Reporting Person's service on the Issuer's Board of Directors (the "Board"), the Issuer granted to the Reporting Person two annual awards of stock options equal to $40,000 of the Issuer's common stock, granted under the Issuer 2019 Long-Term Incentive Plan (the "Incentive Plan"), with (i) the first grant being the right to purchase up to 2,857,141 shares of the Issuer's common stock at a per share exercise price of $0.014 with one-half of such option vesting on March 31, 2020 and the remaining one-half vesting in equal installments on June 30, 2020 and September 30, 2020, respectively, and with an acceleration of any unvested options upon the departure of the Reporting Person from the Board for any reason and F3 · balance_after: (ii) the second grant being the right to purchase up to a number of shares of the Issuer's common stock equal to $40,000 divided by the Fair Market Value (as defined in the Incentive Plan) of the Issuer's common stock as of October 10, 2020 at a per share exercise price equal to Fair Market Value of the Issuer's common stock as of October 10, 2020 with one-fourth of such option vesting on each of December 31, 2020, March 31, 2021, June 30, 2021 and September 30, 2021, respectively, and with an acceleration of any unvested options upon the departure of the Reporting Person from the Board for any reason. This award was reported in the Issuer's Form 10-Q for the period ended March 31, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.